Formulary Search
A to Z of Drugs : T
Records returned : 162 (on 29 May 2025 at 00:45:03).
Show Icon and Status Keys
Drug
Indication
Status
Restrictions/Comments
Formulary Status
Links
Indication :
Status :
Formulations :
- Capsules
- Modified release capsules
- Modified release tablets
- Tablets
Restrictions / Comments:
Important
For EXISTING patients: GPs may continue to prescribe for existing post-transplant patients only. NHS England are looking to repatriate these patients in the future. GPs must not accept any new requests to prescribe for new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
For NEW patients: RED drug for post-transplant. Funded by NHS England. GPs should not accept any requests to prescribe post-transplant.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Preferred
2.5mg tadalafil is non-formulary.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- 2.5mg ONCE DAILY
Restrictions / Comments:
Important
Once daily tadalafil 2.5mg is non-formulary.
Sildenafil is 1st line. Tadalafil (10mg, 20mg or 5mg) is an alternative.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- ONCE DAILY
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
2.5mg tablets are non-formulary (very costly)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- 2.5mg ONCE DAILY
Restrictions / Comments:
Important
2.5mg tablets are non-formulary (very costly)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
SASH only - under shared care agreement with tertiary centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free)
Restrictions / Comments:
Important
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
1st month supply from specialist team before request for primary care prescribing
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Specialist initiation and prescribing for at least 1 month before any request is made for primary care prescribing.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Off-label use. Gynaecomastia prevention in men undergoing long-term bicalutamide treatment, if radiotherapy unsuccessful
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
Restrictions / Comments:
Preferred
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Use modified release capsules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
- Tablets
Restrictions / Comments:
Important
Only on recommendation by a pain specialist for patients not responding to / not tolerating morphine or oxycodone
To be prescribed on recommendation from a specialist.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
NHSE Specialised Commissioning. Not currently commissioned from ASPH, RSFT or SASH
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation. Follow local guidelines on the use of antimicrobials. This drug requires Therapeutic Drug Monitoring.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Non-formulary for new patients, but current patients may continue
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous injection (IV)
Restrictions / Comments:
Important
10,000 unit injection - licensed for acute MI
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Granules
- Tablets
Restrictions / Comments:
Important
RESTRICTED - to be used under advice from Consultant Microbiologist
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Restricted for patients with renal or hepatic failure
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)
Prescribe by BRAND.
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Alternative low carbon DPI (Easyhaler Salbutamol is the more cost-effective treatment option)
Prescribe by BRAND.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Severe acute asthma
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nebules
Restrictions / Comments:
Important
Specialist recommendation following patient initiation and education on nebuliser therapy
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Severe acute asthma
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Under specialist supervision in hospital
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Post-menopausal osteoporosis in women. Rheumatology only.
See separate entry for use in men and juveniles.
Biosimilar teriparatide is recommended. Prescribe by brand.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
RSFT only - commissioned as a Specialised Endocrinology Centre.
See separate entry for use in postmenopausal osteoporosis.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.
Sustanon (Testosterone esters / testosterone propionate / testosterone decanoate)
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.
Testosterone enantate
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.
Tostran gel - SASH - use in smaller children with neuromuscular conditions who need a more gentle induction.
Off-label use
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Off-label use. Initiation and review by the specialist team before any request is made for primary care prescribing.
Testosterone propionate (unlicensed product)
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Prescribe generically as "Testosterone 2% transdermal gel 60g".
See PAD for further information and resources.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Testavan and Testogel do NOT deliver suitable doses for this indication
Prescribe as testosterone 2% transdermal gel (off-label use)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Cream
Restrictions / Comments:
Important
Androfeme is unlicensed in the UK. Other products can be used off-label
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Initiation in primary care on request from specialist team.
Sustanon (Testosterone esters / testosterone propionate / testosterone decanoate)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Initiation in primary care on request from specialist team.
Nebido (testosterone undecanoate)
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Initiation in primary care on request from specialist team.
Testosterone enantate
Links :
Indication :
Status :
Formulations :
- Gel
Restrictions / Comments:
Important
Initiation in primary care on request from specialist team.
Testavan, Testogel, Tostran - prescribe by brand to avoid errors and confusion. Multiple doses and delivery methods (sachets, pumps, tubes).
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Gel
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Includes choreas, Huntington's chorea, dyskinesia, hemiballismus
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
0.5% and 1% preservative free eye drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Depot injection
- Intravenous injection (IV)
Restrictions / Comments:
Important
IV injection - 30 minute diagnostic test
IM injection - 5 hour diagnostic test
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE Specialist Commissioned Services only
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
on formulary for other non-infection indications
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Severe dry eye
Prescribe by brand. Prescribe on specialist recommendation
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Place in therapy under review. Therapeutic drug monitoring required. Not recommended for primary care initiation without specialist advice.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
For supplementation in cases of concern regarding deficiency post-surgery.
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribe generically
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Clopidogrel is the preferred option. Specialist initiation and at least one month supply before transfer to primary care
Formulary Status :
Links :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Clopidogrel is the preferred option. Specialist initiation and at least one month supply before transfer to primary care
Reserve for use in patients with swallowing difficulties.
Links :
Indication :
Status :
Formulations :
- Infusion
Restrictions / Comments:
Important
Restricted Use - for use when indicated by local trust antimicrobial guidelines or specialist microbiology recommendation.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
0.25% and 0.5% eye drops. Prescribe generically. Initiation by specialist team before transfer of prescribing to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye gel
Restrictions / Comments:
Important
0.25% and 0.5% gel-forming solution (Timoptol-LA)
Initiation by specialist team before transfer of prescribing to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
0.1% (1mg/g) preservative free eye gel. Once daily use.
Initiation by specialist team before transfer of prescribing to primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Restricted to use in infants only
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Links :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Specialist initiation and at least one month supply before transfer to primary care (excluding obstetric and cancer patients).
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Off-label use.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Safety concerns with device. Combination of LAMA and LABA recommended in COPD.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhaler (dry powder)
Restrictions / Comments:
Important
Expensive device, no advantage over other LAMAs, and combination with LABA recommended in COPD.
Not for initiation in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soft mist inhaler
Restrictions / Comments:
Important
Only LAMA licensed in asthma.
Prescribe by BRAND.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soft mist inhaler
Restrictions / Comments:
Important
Combination with LABA recommended in COPD.
Prescribe by BRAND.
Formulary Status :
Links :
87. Tiotropium with olodaterol (Spiolto Respimat)
Drug:
Tiotropium with olodaterol (Spiolto Respimat)
(LAMA LABA)
Indication :
Status :
Formulations :
- Soft mist inhaler
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Restrictions / Comments:
Important
Restricted Antimicrobial - requires GUM Specialist approval
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Restricted to cardiology consultants
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Dulaglutide is the preferred weekly injection. Semaglutide is an alternative for weekly injections.
Tirzepatide is 3rd line where dulaglutide / semaglutide are unsuitable or unavailable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Important
Access through the specialist weight management service at Ashford & St Peters NHS Foundation Trust ONLY
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intramuscular injection (IM)
Restrictions / Comments:
Important
Not recommended under NICE TA971
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Specialist to retain prescribing for first 4 months. Monitor liver function.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Inhalation
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravenous infusion
Restrictions / Comments:
Important
Severe disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
Specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
- Tablets (slow release)
Restrictions / Comments:
Important
For use in ankylosing spondylitis only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Ulcerative colitis - adults only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Severe disease only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
1st line in patients with renal impairment
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
Switch to solifenacin (or formulary alternative) recommended
Formulary Status :
Links :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
NHSE specialised commissioning - RSFT only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Prescribing by nephrologists only.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Pregnancy Prevention Plan required for females of childbearing potential.
Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets.
Liquid reserved for patients who cannot swallow tablets or capsules
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Pregnancy Prevention Plan required for females of childbearing potential.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Pregnancy Prevention Plan required for females of childbearing potential.
Capsules (Sprinkle) reserved for use in patients who cannot swallow tablets.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
Restrictions / Comments:
Important
Pregnancy Prevention Plan required for females of childbearing potential.
Only use where patient cannot swallow tablets or capsules (sprinkle) are not suitable.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Consider use where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Modified release tablets
Restrictions / Comments:
Important
Branded prescribing is recommended for modified release tramadol. Do not confuse 12 hourly and 24 hourly preparations.
Consider tramadol where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Soluble tablets
Restrictions / Comments:
Important
Reserved for patients unable to swallow solid dose forms or for administration via an enteral tube.
Consider use where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oro-dispersible
Restrictions / Comments:
Important
Reserved for patients unable to swallow solid dose forms or for administration via an enteral tube.
Consider use where maximum tolerated doses of codeine / dihydrocodeine are ineffective.
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral drops
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
- Soluble tablets
Restrictions / Comments:
Important
NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release capsules
- Modified release tablets
Restrictions / Comments:
Important
NICE CG 173 Consider tramadol only if acute rescue therapy is needed. Prescribe a short course (2-4 weeks on an acute script) and review at least every 3 months.
MR preparations to be prescribed by brand. Marol MR tablets are the locally preferred brand for primary care.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Includes menorrhagia, epistaxis and local fibrinolysis
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Includes menorrhagia, epistaxis and local fibrinolysis
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
Includes menorrhagia, epistaxis and local fibrinolysis
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
short term prophylaxis
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Mouthwash
- Soluble tablets
Restrictions / Comments:
Important
5% mouthwash - unlicensed product. Used in line with St Luke's SACT protocols
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
SASH - Tablets used to make a mouthwash (off-label use). Use in line with St Luke's SACT protocols
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Tablets
Restrictions / Comments:
Important
Initiation and stabilisation by specialist for a minimum of 6 months before transfer of prescribing to primary care.
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Links :
Indication :
Status :
Formulations :
- Eye drops
Restrictions / Comments:
Important
Prescribe generically.
Initiation by specialist team before transfer of prescribing to primary care
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHS England - specialist centres only
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Nasal spray
Restrictions / Comments:
Important
Mometasone Furoate 50mcg/dose (140 dose container) is the preferred intranasal steroid for allergic rhinitis. Triamcinolone is considered to be a 3rd / 4th line agent.
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intravitreal injection
Restrictions / Comments:
Important
ophthalmic suspension 40mg/ml. Intracinol is not a licensed product.
Kenalog is off label.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intracameral injection
- Intravitreal injection
Restrictions / Comments:
Important
40mg/mL Preservative Free Ophthalmic Suspension (Medical Device)
RSCH: also used for subtenon / orbital floor injections
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intra-articular injection
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Intra-articular injection
Restrictions / Comments:
Links :
Indication :
Status :
Formulations :
- Capsules
- Tablets
Restrictions / Comments:
Important
Use only by a Wilson's specialist, with input from a specialist teriary centre.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Paediatrics only. Transfer to primary care only after initiation and stabilisation.
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Off-label use. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team
Links :
Indication :
Status :
Formulations :
- Oral solution
- Tablets
Restrictions / Comments:
Important
Off-label use. 2nd-line option in children over 3 years. Transfer of prescribing responsibility to primary care after initiation and stabilisation of treatment - minimum of 1 month supply from the specialist team
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Oral suspension
- Tablets
Restrictions / Comments:
Important
Follow local guidelines on the use of antimicrobials.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Subcutaneous injection (sc)
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
Primary Care prescribing appropriate on recommendation from the specialist team.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Important
EXISTING patients only. Do not initiate in new patients.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Eye drops (preservative free
- unit dose)
Restrictions / Comments:
Important
0.5% and 1% unit dose eye drops
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Intracameral injection
Restrictions / Comments:
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Immediate release tablets
Restrictions / Comments:
Important
Alternative 1st line in patients where anticholinergic burden is a problem or on medicines that interact.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Modified release tablets
Restrictions / Comments:
Important
2nd line in patients where anticholinergic burden is a problem or on medicines that interact.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Capsules
Restrictions / Comments:
Important
This drug has not yet been assessed for formulary status. Contact your pharmacy team for advice on making an application to APC.
Formulary Status :
Links :
Indication :
Status :
Formulations :
- Not Specified
Restrictions / Comments:
Important
NHSE commissioned services only. No Surrey Heartlands Trusts are commissioned to provide this.
Formulary Status :
Links :